Literature DB >> 20490743

Phenothiazines in migraine treatment.

Marcelo E Bigal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20490743     DOI： 10.1007/s11916-010-0116-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


× No keyword cloud information.
  15 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Clinical practice guidelines.

Authors:  S D Silberstein
Journal:  Cephalalgia       Date:  2005-10       Impact factor: 6.292

3.  Empathy and the failure to treat pain.

Authors:  Steven D Passik; Karen Byers; Kenneth L Kirsh
Journal:  Palliat Support Care       Date:  2007-06

4.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

Review 5.  Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine.

Authors:  R Burstein; D Levy; M Jakubowski
Journal:  Rev Neurol (Paris)       Date:  2005-07       Impact factor: 2.607

Review 6.  Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.

Authors:  W E Pryse-Phillips; D W Dodick; J G Edmeads; M J Gawel; R F Nelson; R A Purdy; G Robinson; D Stirling; I Worthington
Journal:  CMAJ       Date:  1997-05-01       Impact factor: 8.262

7.  Treatment patterns of isolated benign headache in US emergency departments.

Authors:  David R Vinson
Journal:  Ann Emerg Med       Date:  2002-03       Impact factor: 5.721

8.  A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.

Authors:  Benjamin W Friedman; David Esses; Clemencia Solorzano; Niels Dua; Peter Greenwald; Radu Radulescu; Esther Chang; Michael Hochberg; Caron Campbell; Amish Aghera; Tyson Valentin; Joseph Paternoster; Polly Bijur; Richard B Lipton; E John Gallagher
Journal:  Ann Emerg Med       Date:  2007-11-19       Impact factor: 5.721

9.  Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.

Authors:  M E Bigal; C A Bordini; S J Tepper; J G Speciali
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

Review 10.  Excessive acute migraine medication use and migraine progression.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2008-11-25       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.